DK1015494T3 - Fremgangsmåde til fremstilling af katalytiske antistoffer - Google Patents

Fremgangsmåde til fremstilling af katalytiske antistoffer

Info

Publication number
DK1015494T3
DK1015494T3 DK98943578T DK98943578T DK1015494T3 DK 1015494 T3 DK1015494 T3 DK 1015494T3 DK 98943578 T DK98943578 T DK 98943578T DK 98943578 T DK98943578 T DK 98943578T DK 1015494 T3 DK1015494 T3 DK 1015494T3
Authority
DK
Denmark
Prior art keywords
growth factor
present
factor precursor
catalytic antibodies
nucleic acid
Prior art date
Application number
DK98943578T
Other languages
English (en)
Inventor
Herbert Rudolf Treutlein
Gabriele Maria Suess
David Mathew Tarlinton
Frank Koentgen
Original Assignee
Frank Koentgen
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Frank Koentgen filed Critical Frank Koentgen
Application granted granted Critical
Publication of DK1015494T3 publication Critical patent/DK1015494T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/0002—Antibodies with enzymatic activity, e.g. abzymes
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/60—Immunoglobulins specific features characterized by non-natural combinations of immunoglobulin fragments
    • C07K2317/62—Immunoglobulins specific features characterized by non-natural combinations of immunoglobulin fragments comprising only variable region components
    • C07K2317/622—Single chain antibody (scFv)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/60—Immunoglobulins specific features characterized by non-natural combinations of immunoglobulin fragments
    • C07K2317/62—Immunoglobulins specific features characterized by non-natural combinations of immunoglobulin fragments comprising only variable region components
    • C07K2317/624—Disulfide-stabilized antibody (dsFv)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Zoology (AREA)
  • Microbiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
DK98943578T 1997-09-19 1998-09-18 Fremgangsmåde til fremstilling af katalytiske antistoffer DK1015494T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
AUPO9306A AUPO930697A0 (en) 1997-09-19 1997-09-19 Catalytic antibodies and a method of producing same

Publications (1)

Publication Number Publication Date
DK1015494T3 true DK1015494T3 (da) 2006-05-01

Family

ID=3803589

Family Applications (1)

Application Number Title Priority Date Filing Date
DK98943578T DK1015494T3 (da) 1997-09-19 1998-09-18 Fremgangsmåde til fremstilling af katalytiske antistoffer

Country Status (12)

Country Link
US (3) US6590080B1 (da)
EP (1) EP1015494B1 (da)
AT (1) ATE312845T1 (da)
AU (1) AUPO930697A0 (da)
CA (1) CA2304365A1 (da)
DE (1) DE69832804T2 (da)
DK (1) DK1015494T3 (da)
ES (1) ES2253824T3 (da)
GB (1) GB2345694B (da)
HK (1) HK1029350A1 (da)
NZ (3) NZ515603A (da)
WO (1) WO1999015563A1 (da)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU731580B2 (en) * 1996-03-26 2001-04-05 Frank Koentgen Precursors of catalytic antibodies
BR0314619A (pt) * 2002-09-18 2005-08-02 Univ Montreal Ct Hospitalier Chum Análogos de ghrh
US20050163782A1 (en) 2003-06-27 2005-07-28 Biogen Idec Ma Inc. Modified binding molecules comprising connecting peptides
EP1697415A1 (en) 2003-11-12 2006-09-06 Biogen Idec MA Inc. NEONATAL Fc RECEPTOR (FcRn)-BINDING POLYPEPTIDE VARIANTS, DIMERIC Fc BINDING PROTEINS AND METHODS RELATED THERETO
US20070275873A1 (en) * 2004-04-29 2007-11-29 Heidner Hans W Methods and Compositions Comprising Protein L Immunoglobulin Binding Domains for Cell-Specific Targeting
WO2008035894A1 (en) 2006-09-19 2008-03-27 Sungkyunkwan University Foundation For Corporate Collaboration Antiviral agent against animal viruses
WO2011063395A2 (en) * 2009-11-23 2011-05-26 The Johns Hopkins University Lateral flow device for diagnosing microbial infections
US10585098B2 (en) 2009-11-23 2020-03-10 The Johns Hopkins University Optimizing diagnostics for galactofuranose containing antigens
US9738707B2 (en) 2011-07-15 2017-08-22 Biogen Ma Inc. Heterodimeric Fc regions, binding molecules comprising same, and methods relating thereto
EP2565667A1 (en) 2011-08-31 2013-03-06 Friedrich-Alexander-Universität Erlangen-Nürnberg Direction of arrival estimation using watermarked audio signals and microphone arrays
US20150087810A1 (en) * 2013-09-25 2015-03-26 Cytomx Therapeutics, Inc. Matrix Metalloproteinase Substrates And Other Cleavable Moieties And Methods Of Use Thereof
WO2015095195A1 (en) 2013-12-16 2015-06-25 The Johns Hopkins University Interferon-gamma release assays for diagnosis of invasive fungal infections
DK3628328T3 (da) 2014-01-31 2022-12-05 Cytomx Therapeutics Inc Matriptase- og u-plasminogen-aktivatorsubstrater og andre spaltelige dele og fremgangsmåder til anvendelse deraf
MA41374A (fr) 2015-01-20 2017-11-28 Cytomx Therapeutics Inc Substrats clivables par métalloprotéase matricielle et clivables par sérine protéase et procédés d'utilisation de ceux-ci

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1985002414A1 (en) * 1983-11-29 1985-06-06 Igen, Inc. Method of catalyzing chemical reactions
US5126258A (en) * 1984-09-07 1992-06-30 Scripps Clinic And Research Foundation Molecules with antibody combining sites that exhibit catalytic properties
US4900674A (en) * 1987-05-28 1990-02-13 Scripps Clinic And Research Foundation Antibody combining sites that exhibit amide or ester synthase activity
US5215889A (en) * 1988-11-18 1993-06-01 The Regents Of The University Of California Catalytic and reactive polypeptides and methods for their preparation and use
US5190865A (en) * 1988-11-18 1993-03-02 The Regents Of The University Of California Antibody-enhanced stereospecific hydrolyses
US5219732A (en) * 1989-09-05 1993-06-15 The Regents Of The University Of California Antibody-mediated cofactor-driven reactions
US5187086A (en) * 1990-01-26 1993-02-16 Scripps Clinic And Research Foundation Molecules with antibody combining sites that catalyze hydrolysis reactions through use of a charged hapten
SE9002212D0 (sv) * 1990-06-21 1990-06-21 Hightech Receptor Ab Igg binding protein
CA2114934A1 (en) * 1991-08-05 1993-02-18 Mark T. Martin Prodrugs activated by targeted catalytic proteins
ZA931263B (en) * 1992-02-24 1993-11-02 Igen Inc Reaction-based selection for expression of and concentration of catalytic moieties
US5439812A (en) * 1992-04-08 1995-08-08 The Pennsylvania Research Corporation Antibodies catalyzing deamidation of proteins
SE9201331D0 (sv) * 1992-04-28 1992-04-28 Hightech Receptor C O Active Protein l och hybridproteiner daerav
GB9209804D0 (en) * 1992-05-07 1992-06-24 Health Lab Service Board Novel immunoglobulin binding proteins process for their production and recombinant dna molecules coding therefor
EP0935612A4 (en) * 1996-03-26 2001-12-12 Amrad Operations Pty Ltd Precursors of catalytic antibodies
AU731580B2 (en) * 1996-03-26 2001-04-05 Frank Koentgen Precursors of catalytic antibodies
EP1375484A4 (en) * 2001-03-28 2009-08-05 Eisai R&D Man Co Ltd CARBOXYLIC ACIDS
TWI311133B (en) * 2001-04-20 2009-06-21 Eisai R&D Man Co Ltd Carboxylic acid derivativeand the salt thereof
WO2002098840A1 (fr) * 2001-06-04 2002-12-12 Eisai Co., Ltd. Derive de l'acide carboxylique et medicament comprenant un sel ou un ester dudit derive
EP1452521A4 (en) * 2001-08-17 2007-03-14 Eisai R&D Man Co Ltd CYCLIC COMPOUND AND AGONIST OF PPAR RECEPTOR

Also Published As

Publication number Publication date
NZ524429A (en) 2004-06-25
ATE312845T1 (de) 2005-12-15
NZ515603A (en) 2003-04-29
GB2345694B (en) 2002-07-17
US6590080B1 (en) 2003-07-08
AUPO930697A0 (en) 1997-10-09
EP1015494A1 (en) 2000-07-05
GB0009758D0 (en) 2000-06-07
EP1015494A4 (en) 2001-12-12
DE69832804T2 (de) 2006-08-10
US20030148484A1 (en) 2003-08-07
HK1029350A1 (en) 2001-03-30
ES2253824T3 (es) 2006-06-01
EP1015494B1 (en) 2005-12-14
WO1999015563A1 (en) 1999-04-01
GB2345694A (en) 2000-07-19
NZ503454A (en) 2004-01-30
WO1999015563A9 (en) 1999-06-03
US20090269355A1 (en) 2009-10-29
DE69832804D1 (de) 2006-01-19
CA2304365A1 (en) 1999-04-01

Similar Documents

Publication Publication Date Title
DK1015494T3 (da) Fremgangsmåde til fremstilling af katalytiske antistoffer
BR0010806A (pt) Métodos e materiais para a sìntese de produtos orgânicos
MY162525A (en) Process for concentration of antibodies and therapeutic products thereof
HU9303023D0 (en) Peptide nucleicadis and method for producing them
FI942237A0 (fi) Lysosomaalientsyymin pilkkoamia kasvaintenvastaisia lääkeainekonjugaatteja
ATE283916T1 (de) Menschliche metabotropische glutamatrezeptor untertype hmglur7 und verwandte dns-verbindungen
DK0853487T3 (da) Neutraliserende monoklonale antistoffer mod respiratorisk syncytial virus
DK0986644T3 (da) Fremstilling af erythropoietin ved endogen genaktivering med virale promotorer
TR200002731T2 (tr) Proteolitik antikorların indüktör ve inhibitörlerinin tanımlanması, kompozisyonları ve kullanımları için metotlar
EP1808180A3 (en) Modified GP 100 and uses thereof
DE59912185D1 (de) Verwendung von hsp70 protein
KR970705408A (ko) 헤모필루스 부착 및 침투 단백질(haemophilus adherence and penetration proteins)
GB2326643B (en) Precursors of catalytic antibodies
BR0212504A (pt) Materiais e métodos para vacina de células t autólogas
CO5650177A2 (es) Constructos geneticos y composiciones que comprenden rre y cte y usos de estos
ATE505550T1 (de) Fermentationsverfahren
WO2001030989A3 (en) Method for creating divergent populations of nucleic acid molecules and proteins
DK1001929T3 (da) Fremgangsmåde til fremstilling af 3-cyano-2,4-dihalogen-5-flour-benzoesyrer
DE60021875D1 (de) Verfahren zur herstellung von nukleosid-verbindung
ES2177762T3 (es) Procedimiento para producir cis-2-hidrixi-l-prolina.
ITMI910861A1 (it) Procedimento migliorato per la preparazione di polipeptidi maturi
Parikh Purification and characterization of hemorrhagic factor from Crotalus atrox (Western diamondback rattlesnake) venom by high performance liquid chromatography (HPLC) and production of monoclonal antibody.
HUT53593A (en) Process for producing optically active n-(terc butoxy-carbonyl)-o-benzyl-serine and n-(terc butoxy-carbonyl)-o-benzyl-treonine
MX9802766A (es) Vacuna contra la influenza.